{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:34:45Z","timestamp":1772807685487,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23390038"],"award-info":[{"award-number":["23390038"]}]},{"name":"Chiba Prefecture Genki Zukuri Fund Support Programs"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.cca.2014.12.023","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T16:48:17Z","timestamp":1419439697000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine"],"prefix":"10.1016","volume":"441","author":[{"given":"Madoka","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoshiro","family":"Kuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Mizoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Waragai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Toida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuei","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.12.023_bb0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm2240","article-title":"Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?","volume":"8","author":"Giorgio","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cca.2014.12.023_bb0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/bbrc.2001.4569","article-title":"Polyamine cytotoxicity in the presence of bovine serum amine oxidase","volume":"282","author":"Sharmin","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.12.023_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2008.11.054","article-title":"Acrolein toxicity: Comparison with reactive oxygen species","volume":"378","author":"Yoshida","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.12.023_bb0020","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.12.023_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biocel.2009.07.009","article-title":"Modulation of cellular function by polyamines","volume":"42","author":"Igarashi","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2014.12.023_bb0030","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mnfr.201100068","article-title":"Protein-conjugated acrolein as a biochemical marker of brain infarction","volume":"55","author":"Igarashi","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.cca.2014.12.023_bb0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2014.12.023_bb0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/01.wnl.0000240127.89601.83","article-title":"Aging of the brain, entropy, and Alzheimer disease","volume":"67","author":"Drachman","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2014.12.023_bb0045","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","article-title":"Age but not diagnosis is the main predictor of plasma amyloid \u03b2-protein levels","volume":"60","author":"Fukumoto","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cca.2014.12.023_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2005-1544","article-title":"Plasma levels of A\u03b2 peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease","volume":"65","author":"Sobow","year":"2005","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.cca.2014.12.023_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.cca.2014.12.023_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2010-091501","article-title":"Plasma amyloid-\u03b2 forms in Alzheimer's disease and non-Alzheimer's disease patients","volume":"21","author":"Le Bastard","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cca.2014.12.023_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid \u03b2 proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cca.2014.12.023_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma A\u03b242\/A\u03b240 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cca.2014.12.023_bb0075","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","article-title":"Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging","volume":"20","author":"Lui","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cca.2014.12.023_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.2010.1995","article-title":"Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline","volume":"305","author":"Yaffe","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2014.12.023_bb0085","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1161\/01.STR.0000190004.36793.2d","article-title":"Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke","volume":"36","author":"Tomitori","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2014.12.023_bb0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cca.2012.01.020","article-title":"Inverse correlation between stroke and urinary 3-hydroxypropyl mercapturic acid, an acrolein-glutathione metabolite","volume":"413","author":"Yoshida","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.12.023_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2012-120253","article-title":"Increased protein-conjugated acrolein and amyloid-\u03b240\/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease","volume":"32","author":"Waragai","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cca.2014.12.023_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2014.01.007","article-title":"Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid \u03b240 and \u03b242, and protein-conjugated acrolein","volume":"430","author":"Mizoi","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.12.023_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2009.06.005","article-title":"Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease","volume":"285","author":"Waragai","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2014.12.023_bb0110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2014.12.023_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cca.2014.12.023_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00726-006-0264-7","article-title":"Polyamines in renal failure","volume":"31","author":"Igarashi","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.cca.2014.12.023_bb0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study","volume":"65","author":"O'Bryant","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cca.2014.12.023_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000104478","article-title":"Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment","volume":"24","author":"Shinohara","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.cca.2014.12.023_bb0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/nimg.2000.0582","article-title":"Voxel-based morphometry\u2013the methods","volume":"11","author":"Ashburner","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.cca.2014.12.023_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neulet.2005.03.038","article-title":"Voxel-based morphometry to discriminate early Alzheimer's disease from controls","volume":"382","author":"Hirata","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cca.2014.12.023_bb0145","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.jchromb.2009.09.003","article-title":"Determination of six hydroxyalkyl mercapturic acids in human urine using hydrophilic interaction liquid chromatography with tandem mass spectrometry (HILIC-ESI-MS\/MS)","volume":"878","author":"Eckert","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cca.2014.12.023_bb0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.55.9.809","article-title":"The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis","volume":"55","author":"Gao","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cca.2014.12.023_bb0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.1971.tb11979.x","article-title":"Regional distribution of amino acids in human brain obtained at autopsy","volume":"18","author":"Perry","year":"1971","journal-title":"J Neurochem"},{"key":"10.1016\/j.cca.2014.12.023_bb0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2011.12.143","article-title":"Augmented glutathione synthesis decreases acrolein toxicity","volume":"418","author":"Tomitori","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.12.023_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2012.097","article-title":"Polyamines and their metabolites as diagnostic markers of human diseases","volume":"21","author":"Park","year":"2013","journal-title":"Biomol Ther"},{"key":"10.1016\/j.cca.2014.12.023_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10715760701861373","article-title":"Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment","volume":"42","author":"Bermejo","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.cca.2014.12.023_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.11.001","article-title":"Peripheral markers in neurodegenerative patients and their first-degree relatives","volume":"314","author":"Cristalli","year":"2012","journal-title":"J Neurol Sci"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114005579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114005579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T04:13:44Z","timestamp":1717647224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":35,"alternative-id":["S0009898114005579"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.12.023","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}